Sulabh Pharmaceutical Private Limited - Due diligence report

A 360° intelligence report on Sulabh Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2012-03-14 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
SP Sulabh Pharmaceutical Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sulabh Pharmaceutical Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
45/100
Trust Score
Caution Indicated

Sulabh Pharmaceutical Private Limited is assessed as Caution Indicated with a Trust Score of 45/100. Sulabh Pharmaceutical Private Limited is an active private limited indian non-government company incorporated in 2012, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Sulabh Pharmaceutical Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
45/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
31/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Externally credit-rated (D).

Charges position: 1 open (12.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 31/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • Flagged by authority: BANKS.
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ANITA PRAVINBHAI PRAJAPATI 01234567 Director 01/04/2018 6 yrs Approved
PRAVINKUMAR NARAYANBHAI PRAJAPATI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 45
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (31/100).
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence39/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment30/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 12.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view29/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2023
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
08 May 2019
Director ceased
NARAYANBHAI MOHANLAL PRAJAPATI
23 May 2017
Securities allotted
514125 Equity Shares Without Differential Rights - 4.75 cr raised
26 Oct 2016
Securities allotted
514125 Equity Shares Without Differential Rights - 4.75 cr raised
07 Oct 2016
Charge created
Others - 12.00 cr
13 Oct 2015
Securities allotted
18850 Debentures - 18.85 Lakh raised
05 Oct 2015
Director ceased
ASHWIN MANGALDAS PANDYA
30 Mar 2015
Securities allotted
18850 Debentures - 18.85 Lakh raised
14 Mar 2012
Incorporated
Registered with Roc Mumbai I
Director appointed
ANITA PRAVINBHAI PRAJAPATI (Director)
Director appointed
PRAVINKUMAR NARAYANBHAI PRAJAPATI (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
2 active director(s) / partner(s); board looks stable and experienced.
Carries an external credit rating of D from Care.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
Peer companies will appear here as our matching engine processes this industry.
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sulabh Pharmaceutical Private Limited before audits and certifications: compliance score 31/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sulabh Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Sulabh Pharmaceutical Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 45/100, distress signals and MSME payment-delay disclosures - know whether Sulabh Pharmaceutical Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Sulabh Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sulabh Pharmaceutical Private Limited an active company?

Sulabh Pharmaceutical Private Limited has MCA status “Active” with a compliance score of 31/100 (Caution Indicated).

Is Sulabh Pharmaceutical Private Limited financially healthy?

Sulabh Pharmaceutical Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sulabh Pharmaceutical Private Limited?

Its overall Trust Score is 45/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sulabh Pharmaceutical Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Sulabh Pharmaceutical Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Sulabh Pharmaceutical Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 31/100 (Caution Indicated).

Is it risky to lend to Sulabh Pharmaceutical Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.